• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GAPDH 对于女性骨髓间充质干细胞在肺动脉高压中的优越疗效至关重要。

GAPDH is critical for superior efficacy of female bone marrow-derived mesenchymal stem cells on pulmonary hypertension.

机构信息

Department of Pathophysiology, Tongji Medical College, Huazhong Science and Technology University, Wuhan, People's Republic of China.

出版信息

Cardiovasc Res. 2013 Oct 1;100(1):19-27. doi: 10.1093/cvr/cvt165. Epub 2013 Jun 25.

DOI:10.1093/cvr/cvt165
PMID:23801767
Abstract

AIMS

Pulmonary arterial hypertension, a chronic lung disease, remains an unacceptable prognosis despite significant advances in conventional therapies. Stem cell therapy represents a novel and effective modality. This study was aimed to add new insight in gender differences of bone marrow-derived mesenchymal stem cells on therapy against pulmonary arterial hypertension and the underlying mechanism.

METHODS AND RESULTS

By in vivo experiments, we showed for the first time female bone marrow-derived mesenchymal stem cells possessed a better therapeutic potential against monocrotaline-induced pulmonary arterial hypertension in C57BL/6J mice compared with male counterparts. In vitro experiments demonstrated superior function of female bone marrow-derived mesenchymal stem cells in cell proliferation, migration and [Ca(2+)]i kinetics. Moreover, we unexpectedly found that, compared with male ones, female bone marrow-derived mesenchymal stem cells had a higher expression level of glyceraldehyde-3-phosphate dehydrogenase and manipulations of its expression in female or male bone marrow-derived mesenchymal stem cells profoundly affected their cellular behaviours and therapeutic efficacies against pulmonary arterial hypertension.

CONCLUSION

Our results suggest that glyceraldehyde-3-phosphate dehydrogenase plays a critical role in determining the superior functions of female bone marrow-derived mesenchymal stem cells in cell therapy against pulmonary arterial hypertension by regulating [Ca(2+)]i signal-associated cellular behaviours.

摘要

目的

尽管在常规治疗方面取得了重大进展,但肺动脉高压(一种慢性肺部疾病)的预后仍然不容乐观。干细胞疗法代表了一种新颖而有效的治疗方式。本研究旨在深入了解骨髓间充质干细胞在治疗肺动脉高压方面的性别差异及其潜在机制。

方法和结果

通过体内实验,我们首次表明,与雄性骨髓间充质干细胞相比,雌性骨髓间充质干细胞在 C57BL/6J 小鼠的野百合碱诱导的肺动脉高压治疗中具有更好的治疗潜力。体外实验表明,雌性骨髓间充质干细胞在细胞增殖、迁移和[Ca(2+)]i 动力学方面具有更好的功能。此外,我们出人意料地发现,与雄性骨髓间充质干细胞相比,雌性骨髓间充质干细胞的甘油醛-3-磷酸脱氢酶表达水平更高,并且对雌性或雄性骨髓间充质干细胞中甘油醛-3-磷酸脱氢酶的表达进行操作,会显著影响其细胞行为和对肺动脉高压的治疗效果。

结论

我们的研究结果表明,甘油醛-3-磷酸脱氢酶在通过调节[Ca(2+)]i 信号相关的细胞行为来确定雌性骨髓间充质干细胞在细胞治疗肺动脉高压方面的优越功能方面发挥着关键作用。

相似文献

1
GAPDH is critical for superior efficacy of female bone marrow-derived mesenchymal stem cells on pulmonary hypertension.GAPDH 对于女性骨髓间充质干细胞在肺动脉高压中的优越疗效至关重要。
Cardiovasc Res. 2013 Oct 1;100(1):19-27. doi: 10.1093/cvr/cvt165. Epub 2013 Jun 25.
2
Therapeutic effectiveness of bone marrow-derived mesenchymal stem cell administration against acute pulmonary thromboembolism in a mouse model.骨髓间充质干细胞给药对小鼠急性肺血栓栓塞症的治疗效果
Thromb Res. 2015 May;135(5):990-9. doi: 10.1016/j.thromres.2015.02.009. Epub 2015 Feb 12.
3
Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.人胚胎干细胞来源的间充质干细胞的细胞存活率和旁分泌能力提高,可提高肺动脉高压的治疗潜力。
Cell Transplant. 2012;21(10):2225-39. doi: 10.3727/096368912X653020. Epub 2012 Jul 5.
4
[Administrating bone marrow mesenchymal stem cells to treat the experimental pulmonary arterial hypertension in rats].[给予骨髓间充质干细胞治疗大鼠实验性肺动脉高压]
Zhonghua Yi Xue Za Zhi. 2009 Aug 11;89(30):2110-5.
5
Syngeneic bone marrow mononuclear cells improve pulmonary arterial hypertension through vascular endothelial growth factor upregulation.同基因骨髓单个核细胞通过上调血管内皮生长因子改善肺动脉高压。
Ann Thorac Surg. 2009 Aug;88(2):418-24. doi: 10.1016/j.athoracsur.2009.04.105.
6
Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.使用骨髓来源的内皮样祖细胞挽救野百合碱诱导的肺动脉高压:细胞与内皮型一氧化氮合酶基因联合治疗在已确诊疾病中的疗效
Circ Res. 2005 Mar 4;96(4):442-50. doi: 10.1161/01.RES.0000157672.70560.7b. Epub 2005 Feb 3.
7
[Transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor gene for the treatment of pulmonary hypertension in rats].血管内皮生长因子基因转染的骨髓间充质干细胞移植治疗大鼠肺动脉高压
Zhonghua Yi Xue Za Zhi. 2011 Jul 12;91(26):1847-51.
8
MicroRNAs and mesenchymal stem cells: hope for pulmonary hypertension.微小RNA与间充质干细胞:肺动脉高压的希望
Rev Bras Cir Cardiovasc. 2015 Jul-Sep;30(3):380-5. doi: 10.5935/1678-9741.20150033.
9
Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation.骨髓来源细胞对与肺动脉高压和动脉内膜形成相关的血管重塑的多种贡献。
Circulation. 2007 Jan 30;115(4):509-17. doi: 10.1161/CIRCULATIONAHA.106.655837. Epub 2007 Jan 22.
10
Age-related CXC chemokine receptor-4-deficiency impairs osteogenic differentiation potency of mouse bone marrow mesenchymal stromal stem cells.年龄相关的 CXC 趋化因子受体 4 缺乏会损害小鼠骨髓间充质基质干细胞的成骨分化能力。
Int J Biochem Cell Biol. 2013 Aug;45(8):1813-20. doi: 10.1016/j.biocel.2013.05.034. Epub 2013 Jun 4.

引用本文的文献

1
Multi-photon, label-free photoacoustic and optical imaging of NADH in brain cells.脑细胞中烟酰胺腺嘌呤二核苷酸(NADH)的多光子、无标记光声和光学成像。
Light Sci Appl. 2025 Aug 7;14(1):264. doi: 10.1038/s41377-025-01895-x.
2
Signaling pathways and targeted therapy for pulmonary hypertension.肺动脉高压的信号通路与靶向治疗
Signal Transduct Target Ther. 2025 Jul 1;10(1):207. doi: 10.1038/s41392-025-02287-8.
3
Metabolic Deregulation in Pulmonary Hypertension.肺动脉高压中的代谢失调
Curr Issues Mol Biol. 2023 Jun 3;45(6):4850-4874. doi: 10.3390/cimb45060309.
4
Novel hub genes associated with pulmonary artery remodeling in pulmonary hypertension.与肺动脉高压中肺动脉重塑相关的新型枢纽基因。
Front Cardiovasc Med. 2022 Nov 30;9:945854. doi: 10.3389/fcvm.2022.945854. eCollection 2022.
5
Mesenchymal Stem Cell-derived Nanovesicles as a Credible Agent for Therapy of Pulmonary Hypertension.间质干细胞衍生的纳米囊泡作为肺动脉高压治疗的可信因子。
Am J Respir Cell Mol Biol. 2022 Jul;67(1):61-75. doi: 10.1165/rcmb.2021-0415OC.
6
Effects of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Future Perspectives.间质基质细胞衍生的细胞外囊泡在肺部疾病中的作用:现状与未来展望。
Stem Cell Rev Rep. 2021 Apr;17(2):440-458. doi: 10.1007/s12015-020-10085-8. Epub 2020 Nov 19.
7
Calcium Sensing Receptor Inhibits Growth of Human Lung Adenocarcinoma Possibly via the GSK3β/Cyclin D1 Pathway.钙敏感受体可能通过GSK3β/细胞周期蛋白D1途径抑制人肺腺癌生长。
Front Cell Dev Biol. 2020 Jun 25;8:446. doi: 10.3389/fcell.2020.00446. eCollection 2020.
8
Synergistic Improvement in Children with Cerebral Palsy Who Underwent Double-Course Human Wharton's Jelly Stem Cell Transplantation.接受双疗程人脐带华通氏胶间充质干细胞移植的脑瘫患儿的协同改善
Stem Cells Int. 2019 Sep 17;2019:7481069. doi: 10.1155/2019/7481069. eCollection 2019.
9
Gender-independent efficacy of mesenchymal stem cell therapy in sex hormone-deficient bone loss via immunosuppression and resident stem cell recovery.间充质干细胞通过免疫抑制和驻留干细胞恢复治疗性激素缺乏性骨丢失的性别无关疗效。
Exp Mol Med. 2018 Dec 17;50(12):1-14. doi: 10.1038/s12276-018-0192-0.
10
The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury.性别对新生儿高氧诱导性肺损伤中间充质干细胞(MSC)疗效的影响。
PLoS One. 2016 Oct 6;11(10):e0164269. doi: 10.1371/journal.pone.0164269. eCollection 2016.